Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2026-01-03 @ 8:56 AM
Study NCT ID:
NCT05619861
Status:
UNKNOWN
Last Update Posted:
2022-11-17
First Post:
2022-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAR-T Cells in the Treatment of Malignant Hematological Tumors
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2022/11/09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |